| P50 | author | Susan Shaw Devesa | Q87074382 |
| P2093 | author name string | William F Anderson | |
| | Jorge R Toro | |
| | Porcia T Bradford | |
| P2860 | cites work | Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 | Q28271344 |
| | Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). | Q30479763 |
| | Mycosis fungoides: review of epidemiological observations | Q33916367 |
| | Primary cutaneous lymphomas | Q34024484 |
| | WHO-EORTC classification for cutaneous lymphomas | Q34391006 |
| | Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity. | Q34649380 |
| | Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes. | Q35601120 |
| | Inflamm-aging: autoimmunity, and the immune-risk phenotype | Q35852899 |
| | Primary cutaneous B-cell lymphoma | Q36236164 |
| | T-cell non-Hodgkin lymphoma | Q36279490 |
| | Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study | Q36448975 |
| | Primary cutaneous B-cell lymphoma: classification and treatment | Q36559198 |
| | Mycosis fungoides and sezary syndrome: an update | Q36562224 |
| | Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? | Q36614484 |
| | The non-Hodgkin lymphomas: a review of the epidemiologic literature | Q36778875 |
| | Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types | Q36794073 |
| | Recent advances in cutaneous lymphomas | Q36982921 |
| | Cutaneous lymphoma | Q37104119 |
| | Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features | Q38457987 |
| | Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). | Q40189634 |
| | Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. | Q40754916 |
| | Comparative analysis of two rates | Q41501755 |
| | Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases | Q42670957 |
| | Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients | Q43798226 |
| | Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers | Q44008041 |
| | Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). | Q44415891 |
| | Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003. | Q44533354 |
| | Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. | Q44730506 |
| | Impact of reporting delay and reporting error on cancer incidence rates and trends | Q46759442 |
| | Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases | Q47733216 |
| | Graphical presentation of trends in rates. | Q50598208 |
| | Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. | Q50709872 |
| | Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. | Q51103802 |
| | Survival of mycosis fungoides in patients in the Southeast of England. | Q51832452 |
| | Primary Cutaneous B-Cell Lymphoma and Borrelia burgdorferi Infection in Patients From the Highlands of Scotland | Q58001547 |
| | Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group | Q71772615 |
| | Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma | Q72730282 |
| | Primary and secondary cutaneous diffuse large B-cell lymphomas: a multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation | Q73045432 |
| | Primary cutaneous B-cell lymphoma in Japanese patients | Q73313044 |
| | Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study | Q74371928 |
| | Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States | Q77333558 |
| | Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas | Q77785432 |
| | Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States | Q80889284 |
| | Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases | Q81310617 |
| | Cytomegalovirus seroprevalence is not higher in patients with mycosis fungoides/Sezary syndrome | Q82361338 |
| | Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single-centre study of 203 patients | Q83355792 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| | cutaneous lymphoma | Q1794643 |
| P304 | page(s) | 5064-5073 | |
| P577 | publication date | 2009-03-11 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases | |
| P478 | volume | 113 | |